Colgate-Palmolive shares get buy rating with raised target to $104

Published 16/07/2024, 21:58
Colgate-Palmolive shares get buy rating with raised target to $104

On Tuesday, Colgate-Palmolive Company (NYSE:CL) witnessed an optimistic update from Deutsche Bank as its price target was raised to $104 from the previous $98. The firm maintained a Buy rating on the stock, anticipating an upward risk to the company's full-year earnings and organic sales growth forecasts.

The analyst from Deutsche Bank projected that Colgate-Palmolive's full-year earnings per share (EPS) might climb to $3.56, which is marginally higher than the company's suggested guidance range of $3.36 to $3.53. This increase is attributed to expected growth in organic sales and margins, although it may be somewhat tempered by rising foreign exchange headwinds.

The reaffirmed Buy rating is supported by a Discounted Cash Flow (DCF) analysis, which justifies the elevated price target. Additionally, the analyst foresees a second-quarter EPS of $0.87, a slight increase from the earlier estimate of $0.86 and aligning with the consensus. The prediction includes a substantial gross margin growth of 200 basis points and a consistent advertising and promotion (A&P) investment that exceeds 13% of sales.

Colgate-Palmolive has been performing well, and the analyst's expectations suggest that the company could continue to see robust financial growth. The raised price target reflects a positive outlook for the company's ability to expand its margins and sustain its sales growth amidst market challenges.

In other recent news, Colgate-Palmolive has been the subject of several noteworthy developments. The company's Q1 2024 results showed a robust 6% net sales growth and a significant improvement in gross margins by 310 basis points, despite foreign exchange headwinds. This strong performance is expected to set the stage for a promising year, with projected mid to high single-digit base business earnings per share growth.

In analyst-related news, Morgan Stanley raised the price target for Colgate-Palmolive shares to $103 from $101, citing confidence in the company's ability to sustain high operational and earnings growth. Similarly, Argus increased its price target to $107.00 from $97.00, maintaining a Buy rating due to the company's consistent organic sales growth and commitment to product innovation.

In other company news, Jeff Duncan, representative of South Carolina's 3rd congressional district, sold stocks in Colgate-Palmolive from his Raymond James IRA. This move was prompted by a balance requirement at Raymond James and reflects a shift from individual stocks to a more diversified retirement savings plan. These recent developments highlight the active interest and ongoing changes in Colgate-Palmolive's market performance and strategic positioning.

InvestingPro Insights

As Colgate-Palmolive (NYSE:CL) captures the attention of Deutsche Bank with an upgraded price target, the company's financial health and market performance indicators provide additional insights. With a market capitalization of $79.75 billion, Colgate-Palmolive stands as a significant player in the consumer goods sector. The company's P/E ratio, as of Q1 2024, is at a calculated 29.82, suggesting a relatively high valuation by the market against its earnings. However, the PEG ratio of 0.47 indicates potential undervaluation when factoring in near-term earnings growth, aligning with the Deutsche Bank's positive assessment.

The robust gross profit margin of 59.0% for the last twelve months as of Q1 2024 underlines the company's efficiency in managing production costs and maintaining profitability. This is further complemented by a dividend yield of 2.06%, which, alongside a 4.17% growth in dividends and a track record of 54 consecutive years of dividend payments, showcases the company's commitment to returning value to shareholders. These financial strengths are reflected in the company's stock performance, with a year-to-date price total return of 23.45%, and trading close to its 52-week high at 98.31% of the peak price.

InvestingPro Tips for Colgate-Palmolive highlight the company's impressive gross profit margins and its ability to trade at a low P/E ratio relative to near-term earnings growth. These tips, along with additional insights, are available on InvestingPro, where users can find comprehensive analysis to guide their investment decisions. For those interested in gaining full access to these valuable tips, use coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. With 6 more InvestingPro Tips available, investors can deepen their understanding of Colgate-Palmolive's financial and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.